<SEC-DOCUMENT>0001015820-25-000054-index.html : 20250815
<SEC-HEADER>0001015820-25-000054.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815165234
ACCESSION NUMBER:		0001015820-25-000054
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QIAGEN N.V.
		CENTRAL INDEX KEY:			0001015820
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-38332
		FILM NUMBER:		251225389

	BUSINESS ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912
		BUSINESS PHONE:		31-77-35566-00

	MAIL ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QIAGEN NV
		DATE OF NAME CHANGE:	19960531

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bernard Thierry
		CENTRAL INDEX KEY:			0001815490
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		101 HARTWELL AVENUE
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>